Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.
Since the brain is separated from the blood immune system by a tight barrier, the brain-resident complement system may represent a central player in the immune defense of this compartment against human immunodeficiency virus (HIV). Chronic complement activation, however, may participate in HIV-associated neurodegeneration. Since the level of complement factors in the cerebrospinal fluid is known to be elevated in AIDS-associated neurological disorders, we evaluated the effect of HIV type 1 (HIV-1) on the complement synthesis of brain astrocytes. Incubation of different astrocytic cell lines and primary astrocytes with HIV-1 induced a marked upregulation of the expression of the complement factors C2 and C3. The synthesis of other secreted or membrane-bound complement proteins was not found to be altered. The enhancement of C3 production was measured both on the mRNA level and as secreted protein in the culture supernatants. HIV-1 laboratory strains as well as primary isolates were capable of inducing C3 production with varied effectiveness. The usage of viral coreceptors by HIV-1 was proved to be a prerequisite for the upregulation of C3 synthesis, which was modulated by the simultaneous addition of cytokines. The C3 protein which is secreted after incubation of the cells with HIV was shown to be biologically active as it can participate in the complement cascade.
Speth
C
C
Ludwig Boltzmann Institute for AIDS Research and Institute for Hygiene and Social Medicine, University of Innsbruck, Innsbruck, Austria. cornelia.speth@uibk.ac.at
Stöckl
G
G
Mohsenipour
I
I
Würzner
R
R
Stoiber
H
H
Lass-Flörl
C
C
Dierich
M P
MP
D000906:Antibodies / Q000276:immunology; D001253:Astrocytes / Q000276:immunology* / Q000821:virology*; D003167:Complement Activation; D003175:Complement C2 / Q000096:biosynthesis*; D003176:Complement C3 / Q000096:biosynthesis* / Q000276:immunology; D016207:Cytokines / Q000494:pharmacology; D015658:HIV Infections / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D019713:Receptors, CCR5 / Q000276:immunology / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000276:immunology / Q000378:metabolism; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
D000906:Antibodies; D003175:Complement C2; D003176:Complement C3; D016207:Cytokines; D012333:RNA, Messenger; D019713:Receptors, CCR5; D019718:Receptors, CXCR4